385 Selection of CD8+CD103+CD31- tumor infiltrating lymphocytes (TIL) from bulk cultures enriches tumor-specific reactivity in a patient-agnostic manner

• Steven A Rosenberg,
• Stephanie Goff,
• Frank Lowery,
• Nivedita Ratnam,
• Hyunmi Halas

Affiliations

Steven A Rosenberg

Surgery Branch, National Cancer Institute, Bethesda, Maryland, USA

Stephanie Goff

National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Frank Lowery

National Cancer Institute, Bethesda, MD, United States

Nivedita Ratnam

National Cancer Institute, National Institutes of Health, Bethesda, MD, USA

Hyunmi Halas

National Cancer Institute, National Institutes of Health, Bethesda, MD, USA